Gastrointestinální stromální tumor (GIST)
http://www.gist.nadory.cz/

Diferenciální diagnostika

Literatura

  1. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30(10): 1213-1220.
  2. Miettinen M, Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438(1): 1-12.
  3. Greenson JK. Gastrointestinal stromal tumors and other mesenchymal lesions of the gut. Mod Pathol 2003; 16(4): 366-375.
  4. Miettinen M, Kopczynski J, Makhlouf HR, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003; 27(5): 625-641.
  5. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000; 24(10): 1339-1352.
  6. Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 2001; 25(9): 1121-1133.
  7. Miettinen M, Sarlomo-Rikala M, Sobin LH. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors--a clinicopathologic and immunohistochemical study of eighty-eight cases. Mod Pathol 2001; 14(10): 950-956.
  8. Paal E, Miettinen M. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas. Am J Surg Pathol 2001; 25(11): 1355-1363.
  9. Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brennan MF. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 2001; 8(4): 290-299.
  10. Yamaguchi U, Hasegawa T, Masuda T, et al. Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 2004; 445(2): 142-150.
  11. Frost D, Lasota J, Miettinen M. Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases. Vet Pathol 2003; 40(1): 42-54.
  12. Miettinen MM, Sarlomo-Rikala M, Kovatich AJ, Lasota J. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol 1999; 12(8): 756-762.
  13. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 2005; 13(3): 205-220.
  14. Daimaru Y, Kido H, Hashimoto H, Enjoji M. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol 1988; 19(3): 257-264.
  15. Prevot S, Bienvenu L, Vaillant JC, de Saint-Maur PP. Benign schwannoma of the digestive tract: a clinicopathologic and immunohistochemical study of five cases, including a case of esophageal tumor. Am J Surg Pathol 1999; 23(4): 431-436.
  16. Kwon MS, Lee SS, Ahn GH. Schwannomas of the gastrointestinal tract: clinicopathological features of 12 cases including a case of esophageal tumor compared with those of gastrointestinal stromal tumors and leiomyomas of the gastrointestinal tract. Pathol Res Pract 2002; 198(9): 605-613.
  17. Miettinen M, Shekitka KM, Sobin LH. Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases. Am J Surg Pathol 2001; 25(7): 846-855.
  18. Hou YY, Tan YS, Xu JF, et al. Schwannoma of the gastrointestinal tract: a clinicopathological, immunohistochemical and ultrastructural study of 33 cases. Histopathology 2006; 48(5): 536-545.
  19. Zamecnik M, Mukensnabl P, Sokol L, Michal M. Perineurial cells and nerve axons in gastrointestinal schwannomas: a similarity with neurofibromas. An immunohistochemical study of eight cases. Cesk Patol 2004; 40(4): 150-153.
  20. Tan G, Vitellas K, Morrison C, Frankel WL. Cystic schwannoma of the pancreas. Ann Diagn Pathol 2003; 7(5): 285-291.
  21. Chetty R, Vajpeyi R, Penwick JL. Psammomatous melanotic schwannoma presenting as colonic polyps. Virchows Arch 2007; 451(3): 717-720.
  22. Gibson JA, Hornick JL. Mucosal Schwann cell "hamartoma": clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas. Am J Surg Pathol 2009; 33(5): 781-787.
  23. Loffeld RJ, Balk TG, Oomen JL, van der Putten AB. Upper gastrointestinal bleeding due to a malignant Schwannoma of the stomach. Eur J Gastroenterol Hepatol 1998; 10(2): 159-162.
  24. Riddell RH, Petras RE, Williams GT, Sobin LH. Benign neurogenic tumors and proliferation. In: Riddell RH, Petras RE, Williams GT, et al., eds. Tumors of the intestines Atlas of tumor pathology, Fascicle 32, 3rd series Washington, DC: Armed Forces Institute of Pathology; 2003: 346-351.
  25. Shekitka KM, Sobin LH. Ganglioneuromas of the gastrointestinal tract. Relation to Von Recklinghausen disease and other multiple tumor syndromes. Am J Surg Pathol 1994; 18(3): 250-257.
  26. Chan OT, Haghighi P. Hamartomatous polyps of the colon: ganglioneuromatous, stromal, and lipomatous. Arch Pathol Lab Med 2006; 130(10): 1561-1566.
  27. Burke AP, Helwig EB. Gangliocytic paraganglioma. Am J Clin Pathol 1989; 92(1): 1-9.
  28. Girgis PA, Henthorne WA. Pathologic quiz case. Mass at the ampulla of vater in a 43-year-old man. Gangliocytic paraganglioma. Arch Pathol Lab Med 2002; 126(10): 1239-1240.
  29. Lewin MR, Dilworth HP, Abu Alfa AK, Epstein JI, Montgomery E. Mucosal benign epithelioid nerve sheath tumors. Am J Surg Pathol 2005; 29(10): 1310-1315.
  30. Agaimy A, Wuensch PH. Perineurioma of the stomach. A rare spindle cell neoplasm that should be distinguished from gastrointestinal stromal tumor. Pathol Res Pract 2005; 201(6): 463-467.
  31. Hornick JL, Fletcher CD. Intestinal perineuriomas: clinicopathologic definition of a new anatomic subset in a series of 10 cases. Am J Surg Pathol 2005; 29(7): 859-865.
  32. Chetty R. Myxoid perineurioma presenting as a gastric polyp. Ann Diagn Pathol 2010; 14(2): 125-128.
  33. Chan JK. Images in pathology. GIST versus inflammatory fibroid polyp. Int J Surg Pathol 2001; 9(2): 147.
  34. Vanek J. Gastric submucosal granuloma with eosinophilic infiltration. Am J Pathol 1949; 25(3): 397-411.
  35. Hasegawa T, Yang P, Kagawa N, Hirose T, Sano T. CD34 expression by inflammatory fibroid polyps of the stomach. Mod Pathol 1997; 10(5): 451-456.
  36. Wille P, Borchard F. Fibroid polyps of intestinal tract are inflammatory-reactive proliferations of CD34-positive perivascular cells. Histopathology 1998; 32(6): 498-502.
  37. Kim MK, Higgins J, Cho EY, Ko YH, Oh YL. Expression of CD34, bcl-2, and kit in inflammatory fibroid polyps of the gastrointestinal tract. Appl Immunohistochem Mol Morphol 2000; 8(2): 147-153.
  38. Daum O, Hes O, Vanecek T, et al. Vanek's tumor (inflammatory fibroid polyp). Report of 18 cases and comparison with three cases of original Vanek's series. Ann Diagn Pathol 2003; 7(6): 337-347.
  39. Schildhaus HU, Cavlar T, Binot E, et al. Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J Pathol 2008; 216(2): 176-182.
  40. Lasota J, Wang ZF, Sobin LH, Miettinen M. Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases. Mod Pathol 2009; 22(8): 1049-1056.
  41. Daum O, Hatlova J, Mandys V, et al. Comparison of morphological, immunohistochemical, and molecular genetic features of inflammatory fibroid polyps (Vanek's tumors). Virchows Arch 2010; 456(5): 491-497.
  42. Takahashi Y, Shimizu S, Ishida T, et al. Plexiform angiomyxoid myofibroblastic tumor of the stomach. Am J Surg Pathol 2007; 31(5): 724-728.
  43. Galant C, Rousseau E, Ho Minh Duc DK, Pauwels P. Plexiform angiomyxoid myofibroblastic tumor of the stomach. Am J Surg Pathol 2008; 32(12): 1910.
  44. Yoshida A, Klimstra DS, Antonescu CR. Plexiform angiomyxoid tumor of the stomach. Am J Surg Pathol 2008; 32(12): 1910-1912.
  45. Rau TT, Hartmann A, Dietmaier W, et al. Plexiform angiomyxoid myofibroblastic tumour: differential diagnosis of gastrointestinal stromal tumour in the stomach. J Clin Pathol 2008; 61(10): 1136-1137.
  46. Miettinen M, Makhlouf HR, Sobin LH, Lasota J. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST. Am J Surg Pathol 2009; 33(11): 1624-1632.
  47. Sing Y, Subrayan S, Mqadi B, et al. Gastric plexiform angiomyxoid myofibroblastic tumor. Pathol Int 2010; 60(9): 621-625.
  48. Daum O, Jirasek T, Grossmann P, Mukensnabl P, Michal M. Plexiform fibroma of the colon. Appl Immunohistochem Mol Morphol 2010; 18(5): 483-484.
  49. Eslami-Varzaneh F, Washington K, Robert ME, et al. Benign fibroblastic polyps of the colon: a histologic, immunohistochemical, and ultrastructural study. Am J Surg Pathol 2004; 28(3): 374-378.
  50. Zamecnik M, Chlumska A. Fibroblastic polyp of the colon shares features with Vanek tumor. Am J Surg Pathol 2004; 28(10): 1397-1398; author reply 1398.
  51. Kalof AN, Pritt B, Cooper K, Hyman NH, Blaszyk H. Benign fibroblastic polyp of the colorectum. J Clin Gastroenterol 2005; 39(9): 778-781.
  52. Groisman GM, Polak-Charcon S, Appelman HD. Fibroblastic polyp of the colon: clinicopathological analysis of 10 cases with emphasis on its common association with serrated crypts. Histopathology 2006; 48(4): 431-437.
  53. Zamecnik M, Chlumska A. Perineurioma versus fibroblastic polyp of the colon. Am J Surg Pathol 2006; 30(10): 1337-1339.
  54. Groisman GM, Polak-Charcon S. Fibroblastic polyp of the colon and colonic perineurioma: 2 names for a single entity? Am J Surg Pathol 2008; 32(7): 1088-1094.
  55. Agaimy A, Stoehr R, Vieth M, Hartmann A. Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations. Am J Surg Pathol 2010; 34(11): 1663-1671.
  56. Scott N. NSAID-associated submucosal fibrous nodules of the small intestine. Histopathology 2007; 51(3): 408-410.
  57. Yantiss RK, Nielsen GP, Lauwers GY, Rosenberg AE. Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery: a clinicopathologic study of five cases. Am J Surg Pathol 2003; 27(4): 532-540.
  58. Chatelain D, Manaouil D, Levy P, et al. Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery. Am J Surg Pathol 2004; 28(3): 416; author reply 417.
  59. Zardawi IM, Catterall N, Cox SA. Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery. Am J Surg Pathol 2004; 28(2): 276-277.
  60. Daum O, Vanecek T, Sima R, et al. Reactive nodular fibrous pseudotumors of the gastrointestinal tract: report of 8 cases. Int J Surg Pathol 2004; 12(4): 365-374.
  61. Weynand B, Draguet AP, Bernard P, Marbaix E, Galant C. Calcifying fibrous pseudotumour: first case report in the peritoneum with immunostaining for CD34. Histopathology 1999; 34(1): 86-87.
  62. Hill KA, Gonzalez-Crussi F, Chou PM. Calcifying fibrous pseudotumor versus inflammatory myofibroblastic tumor: a histological and immunohistochemical comparison. Mod Pathol 2001; 14(8): 784-790.
  63. Zamecnik M, Michal M, Boudova L, Sulc M. CD34 expression in calcifying fibrous pseudotumours. Histopathology 2000; 36(2): 183-184.
  64. Kocova L, Michal M, Sulc M, Zamecnik M. Calcifying fibrous pseudotumour of visceral peritoneum. Histopathology 1997; 31(2): 182-184.
  65. Zamecnik M, Boudova L, Sulc M, Michal M. Location of calcifying fibrous pseudotumour: peritoneal predominance. Histopathology 2005; 46(3): 346.
  66. Agaimy A, Bihl MP, Tornillo L, et al. Calcifying fibrous tumor of the stomach: clinicopathologic and molecular study of seven cases with literature review and reappraisal of histogenesis. Am J Surg Pathol 2010; 34(2): 271-278.
  67. Brunn H. Two interesting benign lung tumors of contradictory histopathology. J Thoracic Surg 1939; 9): 119-131.
  68. Spencer H. The pulmonary plasma cell/histiocytoma complex. Histopathology 1984; 8(6): 903-916.
  69. Soga J, Saito K, Suzuki N, Sakai T. Plasma cell granuloma of the stomach. A report of a case and review of the literature. Cancer 1970; 25(3): 618-625.
  70. Isaacson P, Buchanan R, Mepham BL. Plasma cell granuloma of the stomach. Hum Pathol 1978; 9(3): 355-358.
  71. Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol 1990; 94(5): 538-546.
  72. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995; 19(8): 859-872.
  73. Kojimahara K, Mukai M, Yamazaki K, et al. Inflammatory pseudotumor of the stomach: report of a highly infiltrative case with electron microscopic and immunohistochemical studies. Acta Pathol Jpn 1993; 43(1-2): 65-70.
  74. Tada T, Wakabayashi T, Kishimoto H. Plasma cell granuloma of the stomach. A report of a case associated with gastric cancer. Cancer 1984; 54(3): 541-544.
  75. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol 1991; 15(12): 1146-1156.
  76. Donner LR, Trompler RA, White RRt. Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol 1996; 27(10): 1095-1098.
  77. Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Sem Diagn Pathol 1998; 15(2): 85-101.
  78. Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Sem Diagn Pathol 1998; 15(2): 102-110.
  79. Meis-Kindblom JM, Kjellstrom C, Kindblom LG. Inflammatory fibrosarcoma: update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors. Sem Diagn Pathol 1998; 15(2): 133-143.
  80. Nonaka D, Birbe R, Rosai J. So-called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells? Histopathology 2005; 46(6): 604-613.
  81. Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997; 79(2): 294-313.
  82. Cossu A, Lissia A, Dedola MF, et al. Classic follicular dendritic reticulum cell tumor of the lymph node developing in a patient with a previous inflammatory pseudotumor-like proliferation. Hum Pathol 2005; 36(2): 207-211.
  83. Qiu X, Montgomery E, Sun B. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol 2008; 39(6): 846-856.
  84. Montgomery EA, Shuster DD, Burkart AL, et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 2006; 30(12): 1502-1512.
  85. Shintaku M, Fukushima A. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change. Pathol Int 2006; 56(10): 625-628.
  86. Makhlouf HR, Sobin LH. Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to inflammatory fibroid polyps? Hum Pathol 2002; 33(3): 307-315.
  87. Dehner LP. Inflammatory myofibroblastic tumor: the continued definition of one type of so-called inflammatory pseudotumor. Am J Surg Pathol 2004; 28(12): 1652-1654.
  88. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001; 25(11): 1364-1371.
  89. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002; 15(9): 931-938.
  90. Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001; 159(2): 411-415.
  91. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000; 157(2): 377-384.
  92. Milne AN, Sweeney KJ, O'Riordain DS, et al. Inflammatory myofibroblastic tumor with ALK/TPM3 fusion presenting as ileocolic intussusception: an unusual presentation of an unusual neoplasm. Hum Pathol 2006; 37(1): 112-116.
  93. Cole B, Zhou H, McAllister N, Afify Z, Coffin CM. Inflammatory myofibroblastic tumor with thrombocytosis and a unique chromosomal translocation With ALK rearrangement. Arch Pathol Lab Med 2006; 130(7): 1042-1045.
  94. Ma Z, Hill DA, Collins MH, et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003; 37(1): 98-105.
  95. Panagopoulos I, Nilsson T, Domanski HA, et al. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int J Cancer 2006; 118(5): 1181-1186.
  96. Cools J, Wlodarska I, Somers R, et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002; 34(4): 354-362.
  97. Callahan K, Reichard K, Wick M, et al. Immunohistochemistry and FISH on tissue microarrays in the evaluation of inflammatory myofibroblastic tumors. Abstract. Lab Invest 2006; 86 suppl. 1): 8A-9A.
  98. Papouchado B, Kelley ED, Skacel M, Goldblum JR. Analysis of ALK abnormalities in inflammatory myofibroblastic tumors: an immunohistochemical (IHC) and fluorescence in situ hybridization (FISH) study. Abstract. Lab Invest 2006; 86 suppl. 1): 16A.
  99. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007; 31(4): 509-520.
  100. Marino-Enriquez A, Wang WL, Roy A, et al. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 2011; 35(1): 135-144.
  101. Chan JK, Tsang WY, Ng CS. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease. Am J Surg Pathol 1994; 18(5): 517-525.
  102. Hollowood K, Stamp G, Zouvani I, Fletcher CD. Extranodal follicular dendritic cell sarcoma of the gastrointestinal tract. Morphologic, immunohistochemical and ultrastructural analysis of two cases. Am J Clin Pathol 1995; 103(1): 90-97.
  103. Perez-Ordonez B, Erlandson RA, Rosai J. Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 1996; 20(8): 944-955.
  104. Perez-Ordonez B, Rosai J. Follicular dendritic cell tumor: review of the entity. Sem Diagn Pathol 1998; 15(2): 144-154.
  105. Moriki T, Takahashi T, Wada M, et al. Follicular dendritic cell tumor of the mesentery. Pathol Res Pract 1997; 193(9): 629-639; discussion 640-622.
  106. Shen SC, Wu CC, Ng KF, et al. Follicular dendritic cell sarcoma mimicking giant cell carcinoma of the pancreas. Pathol Int 2006; 56(8): 466-470.
  107. Low SE, Menasce LP, Manson CM. Follicular dendritic cell sarcoma: a rare tumor presenting as an abdominal mass. Int J Surg Pathol 2007; 15(3): 315-317.
  108. Nguyen DT, Diamond LW, Hansmann M-L, Hell K, Fischer R. Follicular dendritic cell sarcoma. Identification by monoclonal antibodies in paraffin sections. Appl Immunohistochem 1994; 2(1): 60-64.
  109. Pantanowitz L, Antonioli DA, Pinkus GS, Shahsafaei A, Odze RD. Inflammatory fibroid polyps of the gastrointestinal tract: evidence for a dendritic cell origin. Am J Surg Pathol 2004; 28(1): 107-114.
  110. Miyamoto H, Molena DA, Schoeniger LO, Haodong X. Solitary fibrous tumor of the pancreas: a case report. Int J Surg Pathol 2007; 15(3): 311-314.
  111. Vallat-Decouvelaere AV, Dry SM, Fletcher CD. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol 1998; 22(12): 1501-1511.
  112. Lee WA, Lee MK, Jeen YM, et al. Solitary fibrous tumor arising in gastric serosa. Pathol Int 2004; 54(6): 436-439.
  113. Shidham VB, Chivukula M, Gupta D, Rao RN, Komorowski R. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol Lab Med 2002; 126(10): 1189-1192.
  114. Feakins RM. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome. Histopathology 2005; 46(3): 270-279.
  115. Wong NA, Young R, Malcomson RD, et al. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003; 43(2): 118-126.
  116. Panizo-Santos A, Sola I, Vega F, et al. Predicting Metastatic Risk of Gastrointestinal Stromal Tumors: Role of Cell Proliferation and Cell Cycle Regulatory Proteins. Int J Surg Pathol 2000; 8(2): 133-144.
  117. Miettinen M, Paal E, Lasota J, Sobin LH. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol 2002; 26(3): 301-311.
  118. Jundi M, Lack EE, Brun EA, Esquivel J, Kumar D. Glomus tumor of the duodenum: a case report. Int J Surg Pathol 2004; 12(4): 411-414.
  119. Lo AW, Chow LT, To KF, Yu MY. Gastric glomangiomyoma: a pedunculated extramural mass with a florid angiomyomatous pattern. Histopathology 2004; 44(3): 297-298.
  120. Ernst CB, Abell MR, Kahn DR. Malignant Hemangiopericytoma of the Stomach. Surgery 1965; 58): 351-356.
  121. Cueto J, Gilbert EF, Currie RA. Hemangiopericytoma of the stomach. Am J Surg 1966; 112(6): 943-946.
  122. Goldberger RE, Schein CJ. Hemangiopericytoma of the omentum. Report of a case with a unique presentation and review of the literature. Am Surg 1968; 34(4): 291-295.
  123. Binder SC, Wolfe HJ, Deterling RA, Jr. Intra-abdominal hemangiopericytoma. Report of four cases and review of the literature. Arch Surg 1973; 107(4): 536-543.
  124. Stout AP, Murray MR. Hemangiopericytoma: A Vascular Tumor Featuring Zimmermann's Pericytes. Ann Surg 1942; 116(1): 26-33.
  125. Rosai J. Hemangiopericytoma. In: Rosai J, ed. Rosai and Ackerman´s surgical pathology (9th ed). London: Mosby; 2004: 2290-2291.
  126. Suarez V, Hall C. Mesenteric fibromatosis. Br J Surg 1985; 72(12): 976-978.
  127. Rodriguez JA, Guarda LA, Rosai J. Mesenteric fibromatosis with involvement of the gastrointestinal tract. A GIST simulator: a study of 25 cases. Am J Clin Pathol 2004; 121(1): 93-98.
  128. Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 1990; 14(4): 335-341.
  129. Yantiss RK, Spiro IJ, Compton CC, Rosenberg AE. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol 2000; 24(7): 947-957.
  130. Colombo P, Rahal D, Grizzi F, Quagliuolo V, Roncalli M. Localized intra-abdominal fibromatosis of the small bowel mimicking a gastrointestinal stromal tumor: a case report. World J Gastroenterol 2005; 11(33): 5226-5228.
  131. Miettinen M. Are desmoid tumors kit positive? Am J Surg Pathol 2001; 25(4): 549-550.
  132. Lucas DR, al-Abbadi M, Tabaczka P, et al. c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol 2003; 119(3): 339-345.
  133. Liegl B, Leithner A, Bauernhofer T, et al. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours? Histopathology 2006; 49(6): 576-581.
  134. Mace J, Sybil Biermann J, Sondak V, et al. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 2002; 95(11): 2373-2379.
  135. Allen PW. The fibromatoses: a clinicopathologic classification based on 140 cases. Am J Surg Pathol 1977; 1(3): 255-270.
  136. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999; 18(47): 6615-6620.
  137. Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 2002; 26(10): 1296-1301.
  138. Giarola M, Wells D, Mondini P, et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 1998; 78(5): 582-587.
  139. Miyoshi Y, Iwao K, Nawa G, et al. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 1998; 10(11-12): 591-594.
  140. Montgomery E, Lee JH, Abraham SC, Wu TT. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol 2001; 14(7): 695-701.
  141. Ng TL, Gown AM, Barry TS, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005; 18(1): 68-74.
  142. Fanburg-Smith JC, Miettinen M. Liposarcoma with meningothelial-like whorls: a study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma. Histopathology 1998; 33(5): 414-424.
  143. Nascimento AG, Kurtin PJ, Guillou L, Fletcher CD. Dedifferentiated liposarcoma: a report of nine cases with a peculiar neurallike whorling pattern associated with metaplastic bone formation. Am J Surg Pathol 1998; 22(8): 945-955.
  144. Huang HY, Brennan MF, Singer S, Antonescu CR. Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation. Mod Pathol 2005; 18(7): 976-984.
  145. Schreiber-Facklam H, Bode-Lesniewska B, Frigerio S, Flury R. Primary monophasic synovial sarcoma of the duodenum with SYT/SSX2 type of translocation. Hum Pathol 2007; 38(6): 946-949.
  146. Wong NA, Shelley-Fraser G. Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour. Histopathology 2010; 57(2): 250-258.
  147. Nga ME, Wong AS, Wee A, Salto-Tellez M. Cytokeratin expression in gastrointestinal stromal tumours: a word of caution. Histopathology 2002; 40(5): 480-481.
  148. Rossi G, Sartori G, Valli R, et al. The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour. J Clin Pathol 2005; 58(9): 991-993.
  149. Guillou L, Coindre J, Gallagher G, et al. Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives. Hum Pathol 2001; 32(1): 105-112.
  150. Hiraga H, Nojima T, Abe S, et al. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors. Diagn Mol Pathol 1998; 7(2): 102-110.
  151. Lasota J, Jasinski M, Debiec-Rychter M, et al. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma. Mod Pathol 1998; 11(7): 626-633.
  152. Makhlouf HR, Ahrens W, Agarwal B, et al. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. Am J Surg Pathol 2008; 32(2): 275-281.
  153. Lopez-Guerrero JA, Navarro S, Noguera R, et al. Mutational analysis of the c-KIT AND PDGFRalpha in a series of molecularly well-characterized synovial sarcomas. Diagn Mol Pathol 2005; 14(3): 134-139.
  154. Wright JR, Jr., Kyriakos M, DeSchryver-Kecskemeti K. Malignant fibrous histiocytoma of the stomach. A report and review of malignant fibrohistiocytic tumors of the alimentary tract. Arch Pathol Lab Med 1988; 112(3): 251-258.
  155. Wada Y, Matsushita T, Sarumaru S, et al. Malignant fibrous histiocytoma of the stomach: report of two cases. Surg Today 1998; 28(3): 296-300.
  156. Kanoh T, Shirai Y, Wakai T, Hatakeyama K. Malignant fibrous histiocytoma metastases to the small intestine and colon presenting as an intussusception. Am J Gastroenterol 1998; 93(12): 2594-2595.
  157. Bastian D, Ramaswamy A, Barth PJ, et al. Malignant fibrous histiocytoma of the pancreas: a case report with genetic analysis. Cancer 1999; 85(11): 2352-2358.
  158. Huang CC, Ko SF, Ng SH, et al. Cystic malignant fibrous histiocytoma of the gastrocolic ligament. Br J Radiol 2001; 74(883): 651-653.
  159. Tos AP. Classification of pleomorphic sarcomas: where are we now? Histopathology 2006; 48(1): 51-62.
  160. Al-Agha OM, Igbokwe AA. Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med 2008; 132(6): 1030-1035.
  161. Mentzel T, Calonje E, Wadden C, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996; 20(4): 391-405.
  162. Pritchard DJ, Soule EH, Taylor WF, Ivins JC. Fibrosarcoma--a clinicopathologic and statistical study of 199 tumors of the soft tissues of the extremities and trunk. Cancer 1974; 33(3): 888-897.
  163. Fisher C. Myofibrosarcoma. Virchows Arch 2004; 445(3): 215-223.
  164. Eyden BP, Banerjee SS, Harris M, Mene A. A study of spindle cell sarcomas showing myofibroblastic differentiation. Ultrastruct Pathol 1991; 15(4-5): 367-378.
  165. Montgomery E, Goldblum JR, Fisher C. Myofibrosarcoma: a clinicopathologic study. Am J Surg Pathol 2001; 25(2): 219-228.
  166. Eyden B. The fibronexus in reactive and tumoral myofibroblasts: further characterisation by electron microscopy. Histol Histopathol 2001; 16(1): 57-70.
  167. Montgomery EA, Meis JM. Nodular fasciitis. Its morphologic spectrum and immunohistochemical profile. Am J Surg Pathol 1991; 15(10): 942-948.
  168. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002; 117(2): 188-193.
  169. Altinok G, Himmetoglu C, Gurel B, et al. Clinicopathological features and immunohistochemical staining for c-kit protein (CD117) in metastatic and primary malignant melanoma of the gastrointestinal tract. Abstract. Virchows Arch 2005; 447): 678-679.
  170. Ekfors TO, Kujari H, Isomaki M. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) in the duodenum: the first visceral case. Histopathology 1993; 22(3): 255-259.
  171. Donner LR, Trompler RA, Dobin S. Clear cell sarcoma of the ileum: the crucial role of cytogenetics for the diagnosis. Am J Surg Pathol 1998; 22(1): 121-124.
  172. Zambrano E, Reyes-Mugica M, Franchi A, Rosai J. An osteoclast-rich tumor of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: reports of 6 cases of a GIST simulator. Int J Surg Pathol 2003; 11(2): 75-81.
  173. Taminelli L, Zaman K, Gengler C, et al. Primary clear cell sarcoma of the ileum: an uncommon and misleading site. Virchows Arch 2005; 447(4): 772-777.
  174. Fukuda T, Kakihara T, Baba K, et al. Clear cell sarcoma arising in the transverse colon. Pathol Int 2000; 50(5): 412-416.
  175. Pauwels P, Debiec-Rychter M, Sciot R, et al. Clear cell sarcoma of the stomach. Histopathology 2002; 41(6): 526-530.
  176. Venkataraman G, Quinn AM, Williams J, Hammadeh R. Clear cell sarcoma of the small bowel: a potential pitfall. Case report. APMIS 2005; 113(10): 716-719.
  177. Abdulkader I, Cameselle-Teijeiro J, de Alava E, et al. Intestinal clear cell sarcoma with melanocytic differentiation and extraskeletal myxoid chondrosarcoma rearrangement: report of a case. Int J Surg Pathol 2008; 16(2): 189-193.
  178. Lyle PL, Amato CM, Fitzpatrick JE, Robinson WA. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma. Am J Surg Pathol 2008; 32(6): 858-866.
  179. Garcia JJ, Kramer MJ, Mackey ZB, O'Donnell RJ, Horvai AE. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma. Arch Pathol Lab Med 2006; 130(3): 343-348.
  180. Joo M, Chang SH, Kim H, Gardner JM, Ro JY. Primary gastrointestinal clear cell sarcoma: report of 2 cases, one case associated with IgG4-related sclerosing disease, and review of literature. Ann Diagn Pathol 2009; 13(1): 30-35.
  181. Covinsky M, Gong S, Rajaram V, Perry A, Pfeifer J. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma. Hum Pathol 2005; 36(1): 74-81.
  182. Friedrichs N, Testi MA, Moiraghi L, et al. Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entity. Int J Surg Pathol 2005; 13(4): 313-318.
  183. Granville L, Hicks J, Popek E, et al. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection. Ultrastruct Pathol 2006; 30(1): 111-118.
  184. Comin CE, Novelli L, Tornaboni D, Messerini L. Clear cell sarcoma of the ileum: report of a case and review of literature. Virchows Arch 2007; 451(4): 839-845.
  185. Achten R, Debiec-Rychter M, De Wever I, Sciot R. An unusual case of clear cell sarcoma arising in the jejunum highlights the diagnostic value of molecular genetic techniques in establishing a correct diagnosis. Histopathology 2005; 46(4): 472-474.
  186. Huang W, Zhang X, Li D, et al. Osteoclast-rich tumor of the gastrointestinal tract with features resembling those of clear cell sarcoma of soft parts. Virchows Arch 2006; 448(2): 200-203.
  187. Antonescu CR, Nafa K, Segal NH, Dal Cin P, Ladanyi M. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 2006; 12(18): 5356-5362.
  188. Bonetti F, Pea M, Martignoni G, Zamboni G. PEC and sugar. Am J Surg Pathol 1992; 16(3): 307-308.
  189. Bonetti F, Pea M, Martignoni G, et al. Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology (Phila) 1994; 26(3): 230-236.
  190. Maluf H, Dieckgraefe B. Angiomyolipoma of the large intestine: report of a case. Mod Pathol 1999; 12(12): 1132-1136.
  191. Maesawa C, Tamura G, Sawada H, et al. Angiomyolipoma arising in the colon. Am J Gastroenterol 1996; 91(9): 1852-1854.
  192. Hikasa Y, Narabayashi T, Yamamura M, et al. Angiomyolipoma of the colon: a new entity in colonic polypoid lesions. Gastroenterol Jpn 1989; 24(4): 407-409.
  193. Tazelaar HD, Batts KP, Srigley JR. Primary extrapulmonary sugar tumor (PEST): a report of four cases. Mod Pathol 2001; 14(6): 615-622.
  194. Bonetti F, Martignoni G, Colato C, et al. Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis. Mod Pathol 2001; 14(6): 563-568.
  195. Yanai H, Matsuura H, Sonobe H, Shiozaki S, Kawabata K. Perivascular epithelioid cell tumor of the jejunum. Pathol Res Pract 2003; 199(1): 47-50.
  196. Folpe AL, Goodman ZD, Ishak KG, et al. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am J Surg Pathol 2000; 24(9): 1239-1246.
  197. Genevay M, Mc Kee T, Zimmer G, Cathomas G, Guillou L. Digestive PEComas: a solution when the diagnosis fails to "fit". Ann Diagn Pathol 2004; 8(6): 367-372.
  198. Mhanna T, Ranchere-Vince D, Hervieu V, et al. Clear cell myomelanocytic tumor (PEComa) of the duodenum in a child with a history of neuroblastoma. Arch Pathol Lab Med 2005; 129(11): 1484-1486.
  199. Sadeghi S, Krigman H, Maluf H. Perivascular epithelioid clear cell tumor of the common bile duct. Am J Surg Pathol 2004; 28(8): 1107-1110.
  200. Agaimy A, Wunsch PH. Perivascular epithelioid cell sarcoma (malignant PEComa) of the ileum. Pathol Res Pract 2006; 202(1): 37-41.
  201. Yamamoto H, Oda Y, Yao T, et al. Malignant perivascular epithelioid cell tumor of the colon: report of a case with molecular analysis. Pathol Int 2006; 56(1): 46-50.
  202. Parfitt JR, Bella AJ, Izawa JI, Wehrli BM. Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med 2006; 130(8): 1219-1222.
  203. Shimada S, Harada H, Ishizawa K, Hirose T. Retroperitoneal lipomatous angiomyolipoma associated with amyloid deposition masquerading as well-differentiated liposarcoma. Pathol Int 2006; 56(10): 638-641.
  204. Shimada S, Ishizawa T, Ishizawa K, et al. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol 2006; 37(9): 1123-1129.
  205. Adachi Y, Horie Y, Kitamura Y, et al. CD1a expression in PEComas. Pathol Int 2008; 58(3): 169-173.
  206. Pan CC, Jong YJ, Chai CY, Huang SH, Chen YJ. Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm. Hum Pathol 2006; 37(5): 606-612.
  207. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch 2008; 452(2): 119-132.
  208. Usuda H, Naito M. Multicentric angiosarcoma of the gastrointestinal tract. Pathol Int 1997; 47(8): 553-556.
  209. Leroy X, Saint-Blancard P, Boucher E, et al. [Multifocal epithelioid angiosarcoma of the small intestine. Apropos of a case]. Arch Anat Cytol Pathol 1997; 45(1): 54-56.
  210. Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin BP. Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. Am J Surg Pathol 2004; 28(3): 298-307.
  211. Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology 2003; 43(1): 1-16.
  212. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol 2001; 14(6): 595-603.
  213. Kaplan AM, Creager AJ, Livasy CA, Dent GA, Boggess JF. Intra-abdominal embryonal rhabdomyosarcoma in an adult. Gynecol Oncol 1999; 74(2): 282-285.
  214. Diniz G, Aktas S, Ortac R, et al. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy. Pathol Res Pract 2006; 202(9): 671-677.
  215. Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001; 25(9): 1150-1157.
  216. Yaziji H, Ranaldi R, Verdolini R, et al. Primary alveolar soft part sarcoma of the stomach: a case report and review. Pathol Res Pract 2000; 196(7): 519-525.
  217. Carstens PH. Retroperitoneal sarcoma with features suggestive of alveolar soft part sarcoma. Ultrastruct Pathol 1991; 15(4-5): 509-513.
  218. Ordonez NG. Alveolar soft part sarcoma: a review and update. Adv Anat Pathol 1999; 6(3): 125-139.
  219. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001; 20(1): 48-57.
  220. Zarrin-Khameh N, Kaye KS. Alveolar soft part sarcoma. Arch Pathol Lab Med 2007; 131(3): 488-491.
  221. Do I, Araujo ES, Kalil RK, et al. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas. Pathol Res Pract 2007; 203(3): 127-134.
  222. Kondo S, Yamaguchi U, Sakurai S, et al. Cytogenetic confirmation of a gastrointestinal stromal tumor and ewing sarcoma/primitive neuroectodermal tumor in a single patient. Jpn J Clin Oncol 2005; 35(12): 753-756.
  223. O'Sullivan MJ, Perlman EJ, Furman J, et al. Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study. Hum Pathol 2001; 32(10): 1109-1115.
  224. Maesawa C, Iijima S, Sato N, et al. Esophageal extraskeletal Ewing's sarcoma. Hum Pathol 2002; 33(1): 130-132.
  225. Movahedi-Lankarani S, Hruban RH, Westra WH, Klimstra DS. Primitive neuroectodermal tumors of the pancreas: a report of seven cases of a rare neoplasm. Am J Surg Pathol 2002; 26(8): 1040-1047.
  226. Soulard R, Claude V, Camparo P, et al. Primitive neuroectodermal tumor of the stomach. Arch Pathol Lab Med 2005; 129(1): 107-110.
  227. Wang L, Bhargava R, Zheng T, et al. Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 2007; 9(4): 498-509.
  228. Ng TL, O'Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007; 9(4): 459-463.
  229. Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003; 63(15): 4568-4576.
  230. d´Amore ESG, Ninfo V. Soft tissue small round cell tumors: morphological parameters. Sem Diagn Pathol 1996; 13(3): 184-203.
  231. Meis-Kindblom JM, Stenman G, Kindblom LG. Differential diagnosis of small round cell tumors. Sem Diagn Pathol 1996; 13(3): 213-241.
  232. Lopez-Terrada D. Molecular genetics of small round cell tumors. Sem Diagn Pathol 1996; 13(3): 242-249.
  233. Lae ME, Roche PC, Jin L, Lloyd RV, Nascimento AG. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 2002; 26(7): 823-835.
  234. Zhang J, Dalton J, Fuller C. Epithelial marker-negative desmoplastic small round cell tumor with atypical morphology: definitive classification by fluorescence in situ hybridization. Arch Pathol Lab Med 2007; 131(4): 646-649.
  235. Alaggio R, Rosolen A, Sartori F, et al. Spindle cell tumor with EWS-WT1 transcript and a favorable clinical course: a variant of DSCT, a variant of leiomyosarcoma, or a new entity? Report of 2 pediatric cases. Am J Surg Pathol 2007; 31(3): 454-459.
  236. Wheeler JM, Warren BF, Sica G, Maynard ND. Gastrointestinal stromal tumour (GIST) masquerading as linitis plastica. Histopathology 2004; 44(1): 88-90.
  237. Martland GT, Goodman AJ, Shepherd NA. CD117 expression in oesophageal carcinosarcoma: a potential diagnostic pitfall. Histopathology 2004; 44(1): 77-80.
  238. Hardman WJ, 3rd, Majmudar B. Leiomyomatosis peritonealis disseminata: clinicopathologic analysis of five cases. South Med J 1996; 89(3): 291-294.
  239. Randrianjafisamindrakotroka NS, Baldauf JJ, Philippe E, et al. Leiomyomatosis peritonealis disseminata. Report on two cases and differential diagnosis with peritoneal metastases of a low-grade stromal sarcoma of the ovary. Pathol Res Pract 1995; 191(12): 1252-1257; discussion 1258.
  240. Lausen I, Jensen OJ, Andersen E, Lindahl F. Disseminated peritoneal leiomyomatosis with malignant change, in a male. Virchows Arch A Pathol Anat Histopathol 1990; 417(2): 173-175.
  241. Komatsu M, Tsuchiya S, Kuroda T. Leiomyomatosis peritonealis disseminata occurring in a postmenopausal woman: report of a case. Surg Today 1996; 26(9): 700-703.
  242. Wilson JD, Montague CJ, Salcuni P, Bordi C, Rosai J. Heterotopic mesenteric ossification ('intraabdominal myositis ossificans'): report of five cases. Am J Surg Pathol 1999; 23(12): 1464-1470.
  243. Yannopoulos K, Katz S, Flesher L, Geller A, Berroya R. Mesenteritis ossificans. Am J Gastroenterol 1992; 87(2): 230-233.
  244. Hansen O, Sim F, Marton PF, Gruner OP. Heterotopic ossification of the intestinal mesentery. Report of a case following intraabdominal surgery. Pathol Res Pract 1983; 176(2-4): 125-130.
  245. Myers MA, Minton JP. Heterotopic ossification within the small-bowel mesentery. Arch Surg 1989; 124(8): 982-983.
  246. Marucci G, Spitale LS, Piccinni DJ. [Heterotopic mesenteric ossification. Description of a case]. Pathologica 2000; 92(5): 331-334.
  247. Hakim M, McCarthy EF. Heterotopic mesenteric ossification. AJR Am J Roentgenol 2001; 176(1): 260-261.
  248. Bovo G, Romano F, Perego E, et al. Heterotopic mesenteric ossification ("intraabdominal myositis ossificans''): a case report. Int J Surg Pathol 2004; 12(4): 407-409.
  249. Patel RM, Weiss SW, Folpe AL. Heterotopic mesenteric ossification: a distinctive pseudosarcoma commonly associated with intestinal obstruction. Am J Surg Pathol 2006; 30(1): 119-122.
  250. Zamolyi RQ, Souza P, Nascimento AG, Unni KK. Intraabdominal myositis ossificans: a report of 9 new cases. Int J Surg Pathol 2006; 14(1): 37-41.
  251. Dehner LP, Coffin CM. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Sem Diagn Pathol 1998; 15(2): 161-173.
  252. Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med 1967; 66(5): 884-892.
  253. Mitchinson MJ. The pathology of idiopathic retroperitoneal fibrosis. J Clin Pathol 1970; 23(8): 681-689.
  254. Mitchinson MJ. Retroperitoneal fibrosis revisited. Arch Pathol Lab Med 1986; 110(9): 784-786.
  255. Gilkeson GS, Allen NB. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 1996; 22(1): 23-38.
  256. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344(10): 732-738.
  257. Zen Y, Sawazaki A, Miyayama S, et al. A case of retroperitoneal and mediastinal fibrosis exhibiting elevated levels of IgG4 in the absence of sclerosing pancreatitis (autoimmune pancreatitis). Hum Pathol 2006; 37(2): 239-243.
  258. Baker LR, Mallinson WJ, Gregory MC, et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 1987; 60(6): 497-503.
  259. Hughes D, Buckley PJ. Idiopathic retroperitoneal fibrosis is a macrophage-rich process. Implications for its pathogenesis and treatment. Am J Surg Pathol 1993; 17(5): 482-490.
  260. Reske M, Namiki H. Sclerosing mesenteritis. Report of two cases. Am J Clin Pathol 1975; 64(5): 661-667.
  261. Adachi Y, Mori M, Enjoji M, Ueo H, Sugimachi K. Mesenteric panniculitis of the colon. Review of the literature and report of two cases. Dis Colon Rectum 1987; 30(12): 962-966.
  262. Kelly JK, Hwang WS. Idiopathic retractile (sclerosing) mesenteritis and its differential diagnosis. Am J Surg Pathol 1989; 13(6): 513-521.
  263. Bashir MS, Abbott CR. Mesenteric lipodystrophy. J Clin Pathol 1993; 46(9): 872-874.
  264. Emory TS, Monihan JM, Carr NJ, Sobin LH. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity? Am J Surg Pathol 1997; 21(4): 392-398.
  265. Newman PL, Fletcher CD. Malignant mesenchymoma. Clinicopathologic analysis of a series with evidence of low-grade behaviour. Am J Surg Pathol 1991; 15(7): 607-614.
  266. Brady MS, Perino G, Tallini G, Russo P, Woodruff JM. Malignant mesenchymoma. Cancer 1996; 77(3): 467-473.
  267. Fujiyoshi Y, Nishimura H, Irie K, Morimatsu M. A case of retroperitoneal malignant mesenchymoma. Pathol Int 1994; 44(10-11): 803-807.
  268. Haqqani MT, Krasner N, Ashworth M. Benign mesenchymoma of the stomach. J Clin Pathol 1983; 36(5): 504-507.
  269. Sato N, Zaloudek C, Geelhoed GW, Orenstein JM. Malignant mesenchymoma of the small intestine. Arch Pathol Lab Med 1984; 108(2): 164-167.
  270. Kolda TF, Ro JY, Ordonez NG, et al. Endometrial stromal sarcoma presenting as extrauterine metastases. A morphologic and immunohistochemical approach to diagnosis. Int J Surg Pathol 1997; 5(3 & 4): 105-110.
  271. Fukunaga M, Ishihara A, Ushigome S. Extrauterine low-grade endometrial stromal sarcoma: report of three cases. Pathol Int 1998; 48(4): 297-302.
  272. McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 2001; 39(3): 273-278.
  273. Ulbright TM, Michael H, Loehrer PJ, Donohue JP. Spindle cell tumors resected from male patients with germ cell tumors. A clinicopathologic study of 14 cases. Cancer 1990; 65(1): 148-156.
  274. Pauser U, da Silva MT, Placke J, Klimstra DS, Kloppel G. Cellular hamartoma resembling gastrointestinal stromal tumor: a solid tumor of the pancreas expressing c-kit (CD117). Mod Pathol 2005; 18(9): 1211-1216.
Nahoru
Definice a historie  ·  Morfologie  ·  Molekulární genetika  ·  Prognóza a predikce  ·  Diferenciální diagnostika  ·  Molekulárně genetické a klinické varianty  ·  Naše diagnostické možnosti  ·  Kontakt na autory
Copyright © 2006-2021 Bioptická laboratoř s.r.o.



GIST